"We believe that 2025 will be a pivotal year for SELLAS as we continue to advance our clinical stage portfolio of novel therapeutics for hematologic malignancies,” said Angelos ...

The field of cancer research is beginning to embrace a broader perspective that goes beyond genetic and molecular studies, recognizing the significant role ...